載入...
Bayesian Design of Biosimilars Clinical Programs Involving Multiple Therapeutic Indications
In this paper, we propose a Bayesian design framework for a biosimilars clinical program that entails conducting concurrent trials in multiple therapeutic indications to establish equivalent efficacy for a proposed biologic compared to a reference biologic in each indication to support approval of t...
Na minha lista:
| 發表在: | Biometrics |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7170751/ https://ncbi.nlm.nih.gov/pubmed/31631321 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/biom.13163 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|